Alvotech (ALVOW) Other Accumulated Expenses (2020 - 2025)
Alvotech (ALVOW) reported Other Accumulated Expenses of $100.4 million for Q3 2025, up 98.72% on a YoY basis from $50.5 million in Q3 2024, and up 37.25% quarter-over-quarter from $73.1 million in Q2 2025.
Alvotech (ALVOW) Other Accumulated Expenses (2020 - 2025) Analysis & Trends
Alvotech has reported Other Accumulated Expenses for 6 years, with the latest figure at $100.4 million in Q3 2025.
- For the quarter ending Q3 2025, Other Accumulated Expenses rose 98.72% year-over-year to $100.4 million; the trailing twelve-month figure through Sep 2025 stood at $100.4 million (up 98.72% YoY), and the FY2024 full-year result was $59.4 million, down 5.29% from the prior year.
- Other Accumulated Expenses for Q3 2025 stood at $100.4 million, up from $73.1 million in the prior quarter.
- The five-year high for Other Accumulated Expenses was $100.4 million in Q3 2025, with the low at $42.0 million in Q4 2021.
- Historically, Other Accumulated Expenses has averaged $67.1 million across 5 years, with a median of $64.6 million in 2025.
- Annual changes were most pronounced in 2021 — Other Accumulated Expenses soared 155.92% — and 2024, when it fell 27.1%.
- Alvotech's Other Accumulated Expenses stood at $42.0 million in 2021, then increased by 28.65% to $54.0 million in 2022, then climbed by 16.05% to $62.7 million in 2023, then retreated by 5.29% to $59.4 million in 2024, then surged by 68.97% to $100.4 million in 2025.
- The last three Other Accumulated Expenses figures came in at $100.4 million (Q3 2025), $73.1 million (Q2 2025), and $64.6 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Alvotech | - | - | -22.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 100.38 Mn |
| Jun 30, 2025 | 73.14 Mn |
| Mar 31, 2025 | 64.61 Mn |
| Dec 31, 2024 | 59.40 Mn |
| Sep 30, 2024 | 50.51 Mn |
| Jun 30, 2024 | 62.46 Mn |
| Mar 31, 2024 | 76.01 Mn |
| Dec 31, 2023 | 62.72 Mn |
| Jun 30, 2023 | 85.68 Mn |
| Mar 31, 2023 | 75.10 Mn |
| Dec 31, 2022 | 54.05 Mn |
| Jun 30, 2022 | 66.83 Mn |
| Dec 31, 2021 | 42.01 Mn |
| Dec 31, 2020 | 16.42 Mn |